- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03587051
Low Versus High-glycemic Index Post-exercise Diets for Improving Metabolism and Body Composition
Endurance Training and Post-exercise Low Glycemic Index Recovery Diet for Improving Postprandial Triglycerides
Study Overview
Status
Conditions
Detailed Description
The increase in triglycerides after a meal (i.e. postprandial triglycerides) is a strong risk factor for cardiovascular disease. Overweight/obese individuals have a greater triglyceride response to the same meal compared to lean individuals; therefore they are at greater risk. If exercise is performed the evening before a high-fat breakfast, the postprandial levels of triglycerides after the breakfast are reduced; however, if high glycemic index (GI) foods are consumed after the exercise session, the benefits of exercise on next-day postprandial triglycerides is negated. The investigators recently showed (HSFC funded) that consuming low GI foods after exercise is similar to fasting after exercise and superior to consumption of high GI foods for lowering next-day postprandial triglycerides. Low GI food was also superior for increasing fat oxidation, and lowering insulin, and low and very low density lipoproteins and preventing a decrease in high density lipoproteins. The benefits of an acute exercise session followed by low GI food consumption is now clear; however, it is not known whether this practice over weeks of exercise training results in accumulated and sustained benefits.
The purpose of this study is to determine the chronic effects of consuming low compared to high GI foods after exercise sessions over six weeks in overweight and obese individuals.
Twenty-four overweight and obese males and females will be randomized to consume either high or low GI foods immediately after exercise sessions (four sessions per week, 90 minutes per session, six weeks). At all other times of the day over the six weeks, they will be supplied a moderate GI diet, with calories and macronutrients based on four-day food diaries completed before the study. Two weeks before the intervention, participants will be required to go on the moderate GI diet, as a lead-in. One week into the lead-in, a baseline test will be done to determine postprandial metabolic responses (i.e. triglycerides, low and very low density lipoproteins, high density lipoproteins, insulin, and fat oxidation) after a morning high-fat breakfast. A week later, the same postprandial testing will be carried out the morning after the first exercise and post-exercise consumption of a low or high GI recovery meal. Participants will continue the training and post-exercise food consumption for the next six weeks, with postprandial measures taken again following the final exercise and feeding session. Body composition and aerobic fitness will be determined before and after the six week intervention.
The investigators hypothesize that the low GI post-exercise feeding will be superior to the high GI post-exercise feeding for reducing body fat, improving fat oxidation, and reducing postprandial triglycerides, insulin and other harmful lipids. The results of the study will provide clinicians, exercise professionals and dietitians unique and experimentally tested strategies for their clients to lose body fat and improve metabolic profiles, to reduce the risk of heart disease.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7N 5B2
- University of Saskatchewan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Overweight or obese (BMI 25 or greater)
Exclusion Criteria:
- Smokers
- Diabetic
- Taking medications that affect carbohydrate or lipid metabolism
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Low glycemic index post-exercise diet
Lentil-based post-exercise meal
|
Feeding of a low-glycemic index, lentil meal after 90 minutes of walking exercise
|
ACTIVE_COMPARATOR: High glycemic index post-exercise diet
Instant potato, white bread, and egg white post-exercise meal
|
Feeding of a high-glycemic index meal (i.e.
instant mashed potatoes, white bread, egg whites) after 90 minutes of walking exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial triglycerides
Time Frame: Change from baseline to 1 week and 6 weeks
|
Triglyceride from serum
|
Change from baseline to 1 week and 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial cholesterol
Time Frame: Change from baseline to 1 week and 6 weeks
|
Cholesterol from serum
|
Change from baseline to 1 week and 6 weeks
|
Postprandial low density lipoprotein
Time Frame: Change from baseline to 1 week and 6 weeks
|
Low density lipoprotein from serum
|
Change from baseline to 1 week and 6 weeks
|
Postprandial high density lipoprotein
Time Frame: Change from baseline to 1 week and 6 weeks
|
High density lipoprotein from serum
|
Change from baseline to 1 week and 6 weeks
|
Postprandial glucose
Time Frame: Change from baseline to 1 week and 6 weeks
|
Glucose from serum
|
Change from baseline to 1 week and 6 weeks
|
Postprandial insulin
Time Frame: Change from baseline to 1 week and 6 weeks
|
Insulin from serum
|
Change from baseline to 1 week and 6 weeks
|
Fasting Triglyceride
Time Frame: Change from baseline to 1 week and 6 weeks
|
Triglyceride from serum
|
Change from baseline to 1 week and 6 weeks
|
Fasting cholesterol
Time Frame: Change from baseline to 1 week and 6 weeks
|
Cholesterol from serum
|
Change from baseline to 1 week and 6 weeks
|
Fasting LDL-cholesterol
Time Frame: Change from baseline to 1 week and 6 weeks
|
LDL from serum
|
Change from baseline to 1 week and 6 weeks
|
Fasting HDL-cholesterol
Time Frame: Change from baseline to 1 week and 6 weeks
|
HDL from serum
|
Change from baseline to 1 week and 6 weeks
|
Fasting glucose
Time Frame: Change from baseline to 1 week and 6 weeks
|
Glucose from serum
|
Change from baseline to 1 week and 6 weeks
|
Fasting Insulin
Time Frame: Change from baseline to 1 week and 6 weeks
|
Insulin from serum
|
Change from baseline to 1 week and 6 weeks
|
Postprandial fat oxidation
Time Frame: Change from baseline to 1 week and 6 weeks
|
Fat oxidation assessed by expiratory gases
|
Change from baseline to 1 week and 6 weeks
|
Fat mass
Time Frame: Change from baseline to 6 weeks
|
Fat mass assessed by dual energy x-ray absorptiometry
|
Change from baseline to 6 weeks
|
Waist Girth
Time Frame: Change from baseline to 6 weeks
|
Waist girth assessed by a measurement tape
|
Change from baseline to 6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-171
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypercholesterolemia
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryRecruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Provident Clinical ResearchGlaxoSmithKlineCompletedPrimary HypercholesterolemiaUnited States
-
Addpharma Inc.CompletedPrimary HypercholesterolemiaKorea, Republic of
-
JW PharmaceuticalCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Organon and CoCompletedPrimary Hypercholesterolemia | Homozygous Familial Hypercholesterolemia
-
Merck Sharp & Dohme LLCTerminated
-
Danone JapanCompletedHealthy | Mild HypercholesterolemiaJapan
Clinical Trials on Low glycemic index post-exercise diet
-
Rio de Janeiro State UniversityCompleted
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Completed
-
Universidad Autonoma de Baja CaliforniaTerminated
-
University of SaskatchewanRoyal University Hospital FoundationCompletedGlucose IntoleranceCanada
-
Brigham and Women's HospitalEpilepsy FoundationNot yet recruiting
-
Chinese University of Hong KongUnknown
-
Columbia UniversityAmerican Cancer Society, Inc.; Gabrielle's Angel FoundationActive, not recruitingAcute Lymphoblastic Leukemia, Pediatric | Obesity, PediatricUnited States
-
Taipei Medical University WanFang HospitalUnknown
-
Queen's UniversityTerminatedObesity | Cardiovascular Disease | Metabolic SyndromeCanada
-
Aga Khan UniversityNational Institute of Child Health, Karachi, PakistanNot yet recruiting